Abstract Introduction In October 2010, the US Food and Drug Administration (FDA) issued a
safety communication regarding the risks of atypical fractures of the femur, with …

Objective The goal of this study was to describe medication usage patterns in patients with
type 2 diabetes mellitus (T2DM) initiating treatment with non-insulin antidiabetic drugs …

Abstract In a research article published in BMC Medicine, Onakpoya and colleagues provide
a historical review of withdrawals of medications for safety reasons. However, withdrawn …

The prescription pattern of initial treatment for type 2 dia... : Medicine The prescription pattern of
initial treatment for type 2 diabetes in Beijing from 2011 to 2015 : Medicine Log in or Register Get …

Objective To retrospectively analyse the key factors associated with listing decisions by the
Pharmaceutical Benefits Advisory Committee (PBAC) for medicines for diabetes and its …

Abstract Information on rare adverse effects is often limited when a medication is initially
approved for marketing. Medicines regulators use safety advisories to warn health …

Objectives: Glycemic control can lower the risk of diabetesrelated complications, and
delayed treatment intensification can impede optimal diabetes care. This study examines …

Objective To analyse the impact of drug safety warnings from the European Medicines
Agency (EMA) on drug utilisation and their interaction with information released through …

Purpose Cardiovascular safety alerts about rosiglitazone resulted in regulatory actions in
several countries in 2010, but the Food and Drug Administration eliminated access …

Over the past two decades, therapeutics for diabetes have evolved from drugs with known
heart failure risk to classes with potential benefit for patients with heart failure. As many as …